Yuxian Du

493 citations
30 papers · 283 indexed · h-index 9
Topics
Prostate Cancer Treatment and Research (4 papers)Patient Satisfaction in Healthcare (3 papers)Chronic Kidney Disease and Diabetes (3 papers)

In The Last Decade

Yuxian Du

25 papers receiving 281 citations

Peers

Yuxian Du
Comparison fields: 5 of 86
  • Endocrinology, Diabetes and Metabolism 47
  • General Health Professions 46
  • Cardiology and Cardiovascular Medicine 38
  • Physiology 38
  • Nephrology 35
Replace Michael G. Knight with:
Michael G. Knight United States
Marcela Agudelo‐Botero Mexico
Andrzej Steciwko Poland
Ursula Ellis Canada
Jim Nuovo United States
Lisa M. Lines United States
L. van der Hoek Netherlands
Deanna B. McQuillan United States
José María Inoriza Spain
Alice Shiner United Kingdom
Yuxian Du relative to Michael G. Knight United States Michael G. Knight's profile →
Citations per field
00.5×
Michael G. Knight · 1×
Citations per year

Countries citing papers authored by Yuxian Du

Since Specialization
Citations

This map shows the geographic impact of Yuxian Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxian Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxian Du more than expected).

Fields of papers citing papers by Yuxian Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxian Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxian Du. The network helps show where Yuxian Du may publish in the future.

Co-authorship network of co-authors of Yuxian Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxian Du. A scholar is included among the top collaborators of Yuxian Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxian Du. Yuxian Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 1
6 30
7 5
8 0
9 2
10 8
11 2
12 0
13 38
14 3
15 4
16 9
17 6
18 21
19 18
20 15

About Yuxian Du

Yuxian Du is a scholar working on Nephrology, Pharmacy and Oncology, having authored 30 papers that have together received 283 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Patient Satisfaction in Healthcare (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Geriatrics and Gerontology (24 citations), Nephrology (35 citations) and Pharmacy (15 citations). Yuxian Du has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Shinduk Lee, David Washburn, Jay E. Maddock, Wenxin Wang, Sheldon X. Kong, Julio A. Lamprea‐Montealegre, Michelle M. Estrella, Delphine S. Tuot, Chi D. Chu and Samuel D. Towne. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026